Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
74.23
-1.69 (-2.23%)
At close: Jul 16, 2026, 4:00 PM EDT
74.00
-0.23 (-0.31%)
After-hours: Jul 16, 2026, 6:44 PM EDT
Bright Minds Biosciences Employees
Bright Minds Biosciences had 26 employees as of September 30, 2025. The number of employees increased by 25 or 2,500.00% compared to the previous year.
Employees
26
Change (1Y)
25
Growth (1Y)
2,500.00%
Revenue / Employee
n/a
Profits / Employee
-$753,699
Market Cap
729.17M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 26 | 25 | 2,500.00% |
| Sep 30, 2024 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Omeros | 175 |
| Rigel Pharmaceuticals | 174 |
| ARS Pharmaceuticals | 159 |
| Neurogene | 131 |
| Aura Biosciences | 113 |
| Aclaris Therapeutics | 73 |
| Zevra Therapeutics | 61 |
| Candel Therapeutics | 55 |
DRUG News
- 9 days ago - New Options Listings: Bright Minds Biosciences (DRUG) - GuruFocus
- 6 weeks ago - Bright Minds Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline - The Motley Fool
- 2 months ago - Bright Minds price target raised to $220 from $190 at Piper Sandler - TheFly
- 2 months ago - Bright Minds Biosciences Registration statement: Q2 2026 - Filings
- 2 months ago - Bright Minds Biosciences Registration statement: Q2 2026 - Filings
- 3 months ago - DRUG Initiates Coverage On Bright Minds Biosciences -- Price Target Announced - GuruFocus